메뉴 건너뛰기




Volumn 31, Issue 5, 2012, Pages 481-486

Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi

Author keywords

Antiretroviral therapy; HIV; Malawi; Pregnancy outcomes; Trends

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT DISEASE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALAWI; MALE; MATERNAL DISEASE; PLACENTAL TRANSFER; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK;

EID: 84862807362     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31824d9bd9     Document Type: Article
Times cited : (8)

References (35)
  • 1
    • 79451471817 scopus 로고    scopus 로고
    • Joint United Nations Programme on HIV/AIDS Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS)
    • Joint United Nations Programme on HIV/AIDS. UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2010.
    • (2010) UNAIDS Report on the Global AIDS Epidemic 2010
  • 2
    • 78049252230 scopus 로고    scopus 로고
    • Time for "test and treat" in prevention of mother-to-child transmission programs in low-and middleincome countries
    • Zolfo M, De Weggheleire A, Schouten E, et al. Time for "test and treat" in prevention of mother-to-child transmission programs in low-and middleincome countries. J Acquir Immune Defic Syndr. 2010;55:287-289.
    • (2010) J Acquir Immune Defic Syndr , vol.55 , pp. 287-289
    • Zolfo, M.1    De Weggheleire, A.2    Schouten, E.3
  • 3
    • 0032564576 scopus 로고    scopus 로고
    • Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
    • Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study
    • Lorenzi P, Spicher VM, Laubereau B, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS. 1998;12:F241-F247.
    • (1998) AIDS , vol.12
    • Lorenzi, P.1    Spicher, V.M.2    Laubereau, B.3
  • 4
    • 33646038009 scopus 로고    scopus 로고
    • Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
    • Cotter AM, Garcia AG, Duthely ML, et al. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis. 2006;193:1195-1201.
    • (2006) J Infect Dis , vol.193 , pp. 1195-1201
    • Cotter, A.M.1    Garcia, A.G.2    Duthely, M.L.3
  • 5
    • 34147120217 scopus 로고    scopus 로고
    • Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease 1989-2004
    • Pediatric Spectrum of HIV Disease Consortium
    • Schulte J, Dominguez K, Sukalac T, et al.; Pediatric Spectrum of HIV Disease Consortium. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics. 2007;119:e900-e906.
    • (2007) Pediatrics , vol.119
    • Schulte, J.1    Dominguez, K.2    Sukalac, T.3
  • 6
    • 0037071791 scopus 로고    scopus 로고
    • Antiretroviral therapy during pregnancy and the risk of an adverse outcome
    • Tuomala RE, Shapiro DE, Mofenson LM, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002;346:1863-1870.
    • (2002) N Engl J Med , vol.346 , pp. 1863-1870
    • Tuomala, R.E.1    Shapiro, D.E.2    Mofenson, L.M.3
  • 7
    • 33751255378 scopus 로고    scopus 로고
    • Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth
    • NISDI Perinatal Study Group
    • Szyld EG, Warley EM, Freimanis L, et al.; NISDI Perinatal Study Group. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS. 2006;20:2345-2353.
    • (2006) AIDS , vol.20 , pp. 2345-2353
    • Szyld, E.G.1    Warley, E.M.2    Freimanis, L.3
  • 8
    • 77749316885 scopus 로고    scopus 로고
    • Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
    • P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group
    • Patel K, Shapiro DE, Brogly SB, et al.; P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis. 2010;201:1035-1044.
    • (2010) J Infect Dis , vol.201 , pp. 1035-1044
    • Patel, K.1    Shapiro, D.E.2    Brogly, S.B.3
  • 9
    • 0032991193 scopus 로고    scopus 로고
    • Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?
    • The European Collaborative Study
    • The European Collaborative Study. Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? AIDS.1999;13:119-124.
    • (1999) AIDS , vol.13 , pp. 119-124
  • 11
    • 0033941736 scopus 로고    scopus 로고
    • Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIVinfected pregnant women receiving zidovudine
    • Pediatric AIDS Clinical Trials Group 185 Team
    • Lambert JS, Watts DH, Mofenson L, et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIVinfected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS. 2000;14:1389-1399.
    • (2000) AIDS , vol.14 , pp. 1389-1399
    • Lambert, J.S.1    Watts, D.H.2    Mofenson, L.3
  • 12
    • 0028036309 scopus 로고
    • Maternal human immunodeficiency virus 1 infection and intrauterine growth: A prospective cohort study in Butare Rwanda
    • Bulterys M, Chao A, Munyemana S, et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J. 1994;13:94-100.
    • (1994) Pediatr Infect Dis J , vol.13 , pp. 94-100
    • Bulterys, M.1    Chao, A.2    Munyemana, S.3
  • 13
    • 0032133275 scopus 로고    scopus 로고
    • Perinatal human immunodeficiency virus-1 transmission and intrauterine growth: A cohort study in Butare Rwanda
    • Weng S, Bulterys M, Chao A, et al. Perinatal human immunodeficiency virus-1 transmission and intrauterine growth: a cohort study in Butare, Rwanda. Pediatrics. 1998;102:e24.
    • (1998) Pediatrics , vol.102
    • Weng, S.1    Bulterys, M.2    Chao, A.3
  • 14
    • 78751618054 scopus 로고    scopus 로고
    • Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana
    • Powis KM, Smeaton L, Ogwu A, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr. 2011;56:131-138.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , pp. 131-138
    • Powis, K.M.1    Smeaton, L.2    Ogwu, A.3
  • 15
    • 79960887091 scopus 로고    scopus 로고
    • Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy
    • Powis KM, Kitch D, Ogwu A, et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011;204:506-514.
    • (2011) J Infect Dis , vol.204 , pp. 506-514
    • Powis, K.M.1    Kitch, D.2    Ogwu, A.3
  • 16
    • 79956219438 scopus 로고    scopus 로고
    • Mother-to-child transmission of HIV-1 in sub-Saharan Africa: Past, present and future challenges
    • Taha TE. Mother-to-child transmission of HIV-1 in sub-Saharan Africa: past, present and future challenges. Life Sci. 2011;88:917-921.
    • (2011) Life Sci , vol.88 , pp. 917-921
    • Taha, T.E.1
  • 17
    • 79959929512 scopus 로고    scopus 로고
    • Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: Updated efficacy results of the PEPI-Malawi trial
    • Taha TE, Li Q, Hoover DR, et al. Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial. J Acquir Immune Defic Syndr. 2011;57:319-325.
    • (2011) J Acquir Immune Defic Syndr , vol.57 , pp. 319-325
    • Taha, T.E.1    Li, Q.2    Hoover, D.R.3
  • 18
    • 0032556973 scopus 로고    scopus 로고
    • Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi
    • Taha TE, Dallabetta GA, Hoover DR, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12:197-203.
    • (1998) AIDS , vol.12 , pp. 197-203
    • Taha, T.E.1    Dallabetta, G.A.2    Hoover, D.R.3
  • 19
    • 8944227511 scopus 로고    scopus 로고
    • Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission
    • Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 1996;347:1647-1650.
    • (1996) Lancet , vol.347 , pp. 1647-1650
    • Biggar, R.J.1    Miotti, P.G.2    Taha, T.E.3
  • 20
    • 3042848856 scopus 로고    scopus 로고
    • Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial
    • Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202-209.
    • (2004) JAMA , vol.292 , pp. 202-209
    • Taha, T.E.1    Kumwenda, N.I.2    Hoover, D.R.3
  • 21
    • 0141987840 scopus 로고    scopus 로고
    • Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial
    • Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171-1177.
    • (2003) Lancet , vol.362 , pp. 1171-1177
    • Taha, T.E.1    Kumwenda, N.I.2    Gibbons, A.3
  • 22
    • 33745865223 scopus 로고    scopus 로고
    • A phase III clinical trial of antibiotics to reduce chorioamnionitis- related perinatal HIV-1 transmission
    • Taha TE, Brown ER, Hoffman IF, et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006;C:1313-1321.
    • (2006) AIDS , vol.C , pp. 1313-1321
    • Taha, T.E.1    Brown, E.R.2    Hoffman, I.F.3
  • 23
    • 79959929512 scopus 로고    scopus 로고
    • Post-exposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: Updated efficacy results of the PEPI-Malawi trial
    • Taha TE, Li Q, Hoover DR, et al. Post-exposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial. J Acquir Immune Defic Syndr. 2011;57:319-325.
    • (2011) J Acquir Immune Defic Syndr , vol.57 , pp. 319-325
    • Taha, T.E.1    Li, Q.2    Hoover, D.R.3
  • 24
    • 46949108668 scopus 로고    scopus 로고
    • Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission
    • Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129.
    • (2008) N Engl J Med , vol.359 , pp. 119-129
    • Kumwenda, N.I.1    Hoover, D.R.2    Mofenson, L.M.3
  • 25
    • 0025785368 scopus 로고
    • New Ballard Score, expanded to include extremely premature infants
    • Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417-423.
    • (1991) J Pediatr , vol.119 , pp. 417-423
    • Ballard, J.L.1    Khoury, J.C.2    Wedig, K.3
  • 26
    • 15244351320 scopus 로고    scopus 로고
    • United Nations Children's Fund Geneva, Switzerland: United Nations Children's Fund and World Health Organization
    • United Nations Children's Fund. Low Birthweight: Country, Regional and Global Estimates. Geneva, Switzerland: United Nations Children's Fund and World Health Organization; 2004.
    • (2004) Low Birthweight: Country, Regional and Global Estimates
  • 27
    • 74549131536 scopus 로고    scopus 로고
    • The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity
    • Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88:31-38.
    • (2010) Bull World Health Organ , vol.88 , pp. 31-38
    • Beck, S.1    Wojdyla, D.2    Say, L.3
  • 28
    • 0023624397 scopus 로고
    • Determinants of low birth weight: Methodological assessment and meta-analysis
    • Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65:663-737.
    • (1987) Bull World Health Organ , vol.65 , pp. 663-737
    • Kramer, M.S.1
  • 29
    • 0033638124 scopus 로고    scopus 로고
    • Infant birth weight among women with or at high risk for HIV infection: The impact of clinical, behavioral, psychosocial, and demographic factors
    • Ickovics JR, Ethier KA, Koenig LJ, et al. Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors. Health Psychol. 2000;19:515-523.
    • (2000) Health Psychol , vol.19 , pp. 515-523
    • Ickovics, J.R.1    Ethier, K.A.2    Koenig, L.J.3
  • 30
    • 0035128449 scopus 로고    scopus 로고
    • Correlation between maternal and infant HIV infection and low birth weight: A study in Mombasa, Kenya
    • Mwanyumba F, Claeys P, Gaillard P, et al. Correlation between maternal and infant HIV infection and low birth weight: a study in Mombasa, Kenya. J Obstet Gynaecol. 2001;21:27-31.
    • (2001) J Obstet Gynaecol , vol.21 , pp. 27-31
    • Mwanyumba, F.1    Claeys, P.2    Gaillard, P.3
  • 31
    • 0029813542 scopus 로고    scopus 로고
    • The effect of human immunodeficiency virus infection and drug use on birth characteristics
    • Johnstone FD, Raab GM, Hamilton BA. The effect of human immunodeficiency virus infection and drug use on birth characteristics. Obstet Gynecol. 1996;88:321-326.
    • (1996) Obstet Gynecol , vol.88 , pp. 321-326
    • Johnstone, F.D.1    Raab, G.M.2    Hamilton, B.A.3
  • 32
    • 0025185018 scopus 로고
    • Impact of maternal HIV infection on obstetrical and early neonatal outcome
    • Braddick MR, Kreiss JK, Embree JB, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS. 1990;4:1001-1005.
    • (1990) AIDS , vol.4 , pp. 1001-1005
    • Braddick, M.R.1    Kreiss, J.K.2    Embree, J.B.3
  • 33
    • 79960346745 scopus 로고    scopus 로고
    • Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: Time for a public health approach
    • Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378:282-284.
    • (2011) Lancet , vol.378 , pp. 282-284
    • Schouten, E.J.1    Jahn, A.2    Midiani, D.3
  • 34
    • 47649115323 scopus 로고    scopus 로고
    • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies
    • Antiretroviral Therapy Cohort Collaboration
    • Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
    • (2008) Lancet , vol.372 , pp. 293-299
  • 35
    • 74049164246 scopus 로고    scopus 로고
    • Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States
    • Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr. 2010;53:124-130.
    • (2010) J Acquir Immune Defic Syndr , vol.53 , pp. 124-130
    • Harrison, K.M.1    Song, R.2    Zhang, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.